Pharmacological treatment of myoclonic seizures
First-line treatment in children, young people and adults with myoclonic seizures
- sodium valproate should be offered as first-line treatment to children, young people and adults with newly diagnosed myoclonic seizures, unless it is unsuitable. Follow the MHRA safety advice on sodium valproate
- levetiracetam or topiramate should be considered if sodium valproate is unsuitable or not tolerated. Be aware that topiramate has a less favourable side-effect profile than levetiracetam and sodium valproate. Follow the MHRA safety advice on sodium valproate
Adjunctive treatment in children, young people and adults with myoclonic seizures
- levetiracetam, sodium valproate or topiramate should be offered as adjunctive treatment to children, young people and adults with myoclonic seizures if first-line treatments are ineffective or not tolerated. Follow the MHRA safety advice on sodium valproate
Reference: